<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://hawaiimedicaljournal.org/clinical-research/buprenorphine-vs-methadone-prenatal-neurodevelopmental-risks</loc>
    <news:news>
      <news:publication>
        <news:name>Hawaii Medical Journal</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-19T00:03:23.000Z</news:publication_date>
      <news:title>Buprenorphine vs Methadone: Prenatal Neurodevelopmental Risks</news:title>
      <news:keywords>Opioid Use Disorder, Prenatal Exposure, Buprenorphine, Methadone, Neurodevelopmental Outcomes</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://hawaiimedicaljournal.org/oncology/revolution-medicines-raises-2b-after-pancreatic-cancer-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Hawaii Medical Journal</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-18T18:02:49.000Z</news:publication_date>
      <news:title>Revolution Medicines Raises $2B After Pancreatic Cancer Trial</news:title>
      <news:keywords>Pancreatic Cancer, Revolution Medicines, Daraxonrasib, Oncology Biotech, Clinical Trials</news:keywords>
    </news:news>
  </url>
</urlset>